Objectives To provide a comprehensive and objective summary of contraceptive failure rates
for a variety of methods based on a systematic review of the literature. Methods Medline and …

Background Concern about estrogen‐related adverse effects has led to progressive
reductions in the estrogen dose in combination oral contraceptives (COCs). However …

Objective: To compare the efficacy of a new low-dose oral contraceptive pill (OCP)
formulation with placebo in reducing symptoms of premenstrual dysphoric disorder …

PURPOSE: This multicenter, double-blind, placebo-controlled crossover study evaluated the
efficacy of a new oral contraceptive (OC) formulation containing drospirenone 3 mg and …

The spironolactone derivative drospirenone is combined with ethinylestradiol or estetrol in
combined oral contraceptives. Formulations with 17-β-estradiol are used to treat climacteric …

BACKGROUND: This study compared the bleeding pattern, cycle control and safety of an
oral contraceptive (OC) comprising estradiol valerate/dienogest (E2V/DNG; administered …

BACKGROUND: This study was conducted to compare ovarian activity of an oral
contraceptive containing drospirenone (drsp) 3 mg plus ethinylestradiol (EE) 20 mcg …

BACKGROUND: A prospective randomized trial was conducted to compare efficacy of a
drospirenone-containing combined oral contraceptives (COC) with desogestrel-containing …

Purpose Despite considerable advances in recently developed combined oral
contraceptives (COCs), resulting in lower rates of adverse events while maintaining …

Most women have used at least 1 method of contraception during their reproductive years,
with the majority favoring combined oral contraceptives. Women are often concerned about …